Pacira Pharmaceuticals buy JPMorgan Chase & Co.
Start price
07.03.24
/
50%
€28.20
Target price
07.03.25
€41.38
Performance (%)
-24.11%
End price
08.03.25
€21.40
Summary
This prediction ended on 08.03.25 with a price of €21.40. The price of Pacira Pharmaceuticals has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -24.11%. JPMorgan_Chase___Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Pacira Pharmaceuticals | -2.970% | -2.970% | -13.274% |
| iShares Core DAX® | 2,49 % | -5,94 % | 2,90 % |
| iShares Nasdaq 100 | 1,65 % | -2,46 % | 15,75 % |
| iShares Nikkei 225® | 0,55 % | -7,60 % | 30,35 % |
| iShares S&P 500 | 1,35 % | -2,94 % | 10,34 % |
Comments by JPMorgan_Chase___Co_ for this prediction
In the thread Pacira Pharmaceuticals diskutieren
Pacira BioSciences, Inc. (NASDAQ: PCRX) is now covered by analysts at JPMorgan Chase & Co.. They set an "overweight" rating and a $45.00 price target on the stock.
Ratings data for PCRX provided by MarketBeat
In the thread Trading Pacira Pharmaceuticals
Die von JPMorgan_Chase___Co_ gewählte maximale Laufzeit wurde überschritten
Stopped prediction by JPMorgan_Chase___Co_ for Pacira Pharmaceuticals
Pacira Pharmaceuticals
Start price
Target price
Perf. (%)
€11.10
12.08.24
12.08.24
€9.16
12.08.25
12.08.25
87.39%
13.08.25
13.08.25
